Return to Home Page

Press Release

For Immediate Release Contact: Patricia Sanders
(800) 677-8441

African-American Men Sought for Prostate Cancer Study

African-American men with a history of prostate cancer are being sought to participate in a confidential survey. The data will be used to determine if they meet the criteria for an historic human genome study on hereditary prostate cancer. P&E Associates, an independent pharmaceutical and biogenetic survey organization, is working in partnership with the National Human Genome Institute (NHGI) at Howard University and the African American Hereditary Prostate Cancer (AAHPC) Study Network to locate at least 100 participants by March 31, 2002.

Although more lives are being saved through early detection, African American men continue to show disproportionately higher numbers of deaths. Having access to information and funding is critical in fighting this disease.
"I'm really concerned about prostate cancer. Too many of us are not getting the message," said U.S. Rep. Maxine Waters. "Our men should start getting screenings by age 40. If not, some of them are going to die. My husband gets his check up twice a year."

Recent studies on prostate cancer, done at the National Institute of Health (NIH), indicate that prostate cancer may run in the families of black men. In a previous study of 100 men, only one was African American. In his case, prostate cancer was found in three other family members.
The new study will allow researchers to examine how the disease specifically affects African American men. It is the only genetic study of its type currently being done.

"It is extremely important that more African American families with prostate cancer be included in national studies so that we can find out if this disease does run in the family of more African Americans," said Patricia Sanders, P&E executive director and wife of prostate cancer survivor, Ed Sanders.
The AAHPC Study Network was launched in January 1998 with major funding from the NIH Office of Research on Minority Health, in partnership with the NHGRI. Additional funding has been provided by the National Cancer Institute. More information on Howard's recruitment efforts will appear in the February 2002 issue of Upscale magazine, as well as in other national publications and on national television.

If you or a member of your family has been diagnosed with prostate cancer, or you are a doctor treating prostate cancer patients, please call the toll-free Family Referral Associates Hotline at (800) 677-8441, or visit the website at www.huhosp.org/hucc/research.htm#7


Prostate cancer patients or doctors treating men with prostate cancer can complete the confidential survey online at www.aahpc.resourcez.com.
Thank you for considering this information for print and/or broadcast. A family referral associate will follow up with you within three days. To arrange an interview with Dr. Georgia Dunston of Howard or NHGI scientists working with the AAHPC Study, please call the toll-free Family Referral Associates Hotline at (800) 677-8441.

Very truly yours,


Patricia Sanders
Executive Director
P&E Associates